Literature DB >> 32948682

Chemokine Signatures of Pathogen-Specific T Cells II: Memory T Cells in Acute and Chronic Infection.

Bennett Davenport1,2,3,4,5, Jens Eberlein1,2, Tom T Nguyen1,3, Francisco Victorino1,2,3, Verena van der Heide4,5, Maxim Kuleshov6,7, Avi Ma'ayan6,7, Ross Kedl2, Dirk Homann8,2,3,4,5.   

Abstract

Pathogen-specific memory T cells (TM) contribute to enhanced immune protection under conditions of reinfection, and their effective recruitment into a recall response relies, in part, on cues imparted by chemokines that coordinate their spatiotemporal positioning. An integrated perspective, however, needs to consider TM as a potentially relevant chemokine source themselves. In this study, we employed a comprehensive transcriptional/translational profiling strategy to delineate the identities, expression patterns, and dynamic regulation of chemokines produced by murine pathogen-specific TM CD8+TM, and to a lesser extent CD4+TM, are a prodigious source for six select chemokines (CCL1/3/4/5, CCL9/10, and XCL1) that collectively constitute a prominent and largely invariant signature across acute and chronic infections. Notably, constitutive CCL5 expression by CD8+TM serves as a unique functional imprint of prior antigenic experience; induced CCL1 production identifies highly polyfunctional CD8+ and CD4+TM subsets; long-term CD8+TM maintenance is associated with a pronounced increase of XCL1 production capacity; chemokines dominate the earliest stages of the CD8+TM recall response because of expeditious synthesis/secretion kinetics (CCL3/4/5) and low activation thresholds (CCL1/3/4/5/XCL1); and TM chemokine profiles modulated by persisting viral Ags exhibit both discrete functional deficits and a notable surplus. Nevertheless, recall responses and partial virus control in chronic infection appear little affected by the absence of major TM chemokines. Although specific contributions of TM-derived chemokines to enhanced immune protection therefore remain to be elucidated in other experimental scenarios, the ready visualization of TM chemokine-expression patterns permits a detailed stratification of TM functionalities that may be correlated with differentiation status, protective capacities, and potential fates.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32948682      PMCID: PMC7541577          DOI: 10.4049/jimmunol.2000254

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  81 in total

Review 1.  Chemokines and Chemokine Receptors in Lymphoid Tissue Dynamics.

Authors:  Olga Schulz; Swantje I Hammerschmidt; G Leandros Moschovakis; Reinhold Förster
Journal:  Annu Rev Immunol       Date:  2016-02-22       Impact factor: 28.527

2.  Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.

Authors:  Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Kevin Jhun; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

3.  Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity.

Authors:  Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Tim Sparwasser; Dirk Homann
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

4.  Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection.

Authors:  Scott N Mueller; Mehrdad Matloubian; Daniel M Clemens; Arlene H Sharpe; Gordon J Freeman; Shivaprakash Gangappa; Christian P Larsen; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

Review 5.  CD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesis.

Authors:  Korey R Demers; Morgan A Reuter; Michael R Betts
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

6.  Structural perspectives on antimicrobial chemokines.

Authors:  Leonard T Nguyen; Hans J Vogel
Journal:  Front Immunol       Date:  2012-12-28       Impact factor: 7.561

7.  Accelerated and improved quantification of lymphocytic choriomeningitis virus (LCMV) titers by flow cytometry.

Authors:  Darlynn Korns Johnson; Dirk Homann
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

8.  Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection.

Authors:  Anders Boyd; Jorge R Almeida; Patricia A Darrah; Delphine Sauce; Robert A Seder; Victor Appay; Guy Gorochov; Martin Larsen
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

9.  The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules.

Authors:  Shengli Hao; David Baltimore
Journal:  Nat Immunol       Date:  2009-02-08       Impact factor: 25.606

10.  Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues.

Authors:  A G Farr; M L Berry; A Kim; A J Nelson; M P Welch; A Aruffo
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  3 in total

1.  Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.

Authors:  Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Kevin Jhun; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

2.  Memory CD8+ T cells mediate early pathogen-specific protection via localized delivery of chemokines and IFNγ to clusters of monocytes.

Authors:  Marie Boutet; Zachary Benet; Erik Guillen; Caroline Koch; Saidi M'Homa Soudja; Fabien Delahaye; David Fooksman; Grégoire Lauvau
Journal:  Sci Adv       Date:  2021-09-01       Impact factor: 14.136

3.  Modulation of Host Immune Response during Leishmania infantum Natural Infection: A Whole-Transcriptome Analysis of the Popliteal Lymph Nodes in Dogs.

Authors:  Carolina R Sanz; Guadalupe Miró; Natalia Sevane; Armando Reyes-Palomares; Susana Dunner
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.